Let me be clear from the start: I think the aesthetic industry's casual attitude towards so-called "gentle" or "lunchtime" laser treatments is a recipe for client disappointment and, frankly, wasted clinic budgets. I'm talking specifically about devices like Solta Medical's Clear & Brilliant. We've been conditioned to see them as low-risk, easy-entry options. I'm here to argue that's a flawed and potentially costly mindset. Handling equipment orders and service contracts for the better part of a decade, I've personally approved purchases that looked great on paper but led to underutilized assets gathering dust. One misguided order in early 2022, driven by that "gentle must mean simple" assumption, cost a partner clinic roughly $15,000 in unrealized revenue and tied up capital for months. Now I maintain our clinic's pre-purchase checklist to prevent others from repeating my error.
The "Gentle" Misconception and Its Hidden Costs
The core of the problem is linguistic. Marketing terms like "gentle fractional laser" or "beginner laser" for devices such as Clear & Brilliant create a cognitive shortcut. We start to believe that if the patient downtime is minimal (often 24-48 hours of redness), then the operational complexity and required expertise must also be minimal. That's where the trap is set.
My experience suggests otherwise. In my first year focusing on aesthetic devices (2018), I made the classic error of equating a gentle patient experience with an easy business model. I helped a clinic purchase a Clear & Brilliant system primarily because it was marketed as an "add-on" service. The thinking was: "It's non-ablative, the settings are pre-set, how hard can it be?" The result? The device was used sporadically for about six months. Staff weren't fully confident in explaining its nuanced benefits for skin tone evening or preventative aging compared to more aggressive lasers like Fraxel. Patient conversion for packages was low because the value proposition was fuzzy. A $3,200 order for consumable tips mostly expired. That's when I learned that "gentle" on the skin doesn't mean "simple" in the business plan. It requires a dedicated strategy.
Why Clear & Brilliant Requires More Rigorous Vetting, Not Less
This leads to my second point: precisely because devices like Clear & Brilliant are often a clinic's first laser or an entry-point treatment, the vetting process for providers should be more stringent, not less. Here's the counterintuitive angle: an aggressive, ablative laser like a traditional CO2 system commands immediate respect. Everyone knows it's a serious tool requiring serious training. The perceived "safety" of a gentler laser can lead to complacency in both operator training and patient consultation.
I don't have hard data on industry-wide complication rates comparing device types, but based on tracking service tickets and clinical feedback for hundreds of orders, my sense is that a significant portion of poor outcomes or patient dissatisfaction stems from improper use of "beginner-friendly" devices, not from the high-powered ones. Why? Because with the powerful tools, you're scared into following protocol. With Clear & Brilliant, you might be tempted to wing it or not fully invest in advanced application training. The most frustrating part of reviewing service records: seeing the same issues—like inconsistent results or difficulty managing patient expectations—recurring despite the device being technically simple to operate. You'd think basic training would suffice, but mastering the art of building effective treatment plans with it is a different skill.
The Portfolio Paradox: Strength Becomes a Weakness in Marketing
This is where Solta Medical's own strength—a portfolio of leading brands—can accidentally feed the problem. When a clinic looks at Solta's lineup, they see Thermage for tightening, Fraxel for resurfacing, and Clear & Brilliant. It's easy to slot Clear & Brilliant into the "light" category and mentally reduce its strategic importance. I've seen this in countless procurement conversations.
One of my biggest regrets: not pushing harder for a bundled training and marketing package when a clinic bought a Clear & Brilliant system in 2021. The clinic saw it as a small add-on purchase to their main Fraxel order. The consequence? The Clear & Brilliant was never properly integrated into their service menu. It became an occasional treatment instead of a foundational, recurring revenue stream for skin maintenance. It's still underperforming. The lesson wasn't about the device's capability, which is excellent for its intended purposes like improving skin tone and texture. The lesson was that its positioning within a portfolio requires active management to avoid being marginalized.
Rebuttal: But Isn't It a Perfect Entry Point?
I get why people push back on this. To be fair, Clear & Brilliant is a fantastic entry-point treatment. It has minimal downtime, a good safety profile, and can attract a broader patient base. That's all true. My argument isn't that it's a bad device—it's a great one. My argument is that the very factors that make it a good entry point also make it vulnerable to being undervalued and underutilized. Granted, not every clinic needs to build a whole program around it. But if you're investing tens of thousands of dollars, you owe it to yourself to treat it with the same strategic rigor as you would a "major" device. The "gentle" label should inform the patient experience, not dilute the operational planning.
The New Checklist: Respecting the "Gentle" Workhorse
After the Q1 2022 mistake, I created our pre-purchase checklist for "low-downtime" aesthetic tech. It doesn't focus on technical specs first. It starts with business questions:
- Who on staff will be the champion for this device, and what advanced training will they pursue beyond the basics?
- How will we message it differently from our other laser treatments (e.g., Fraxel for significant damage, Clear & Brilliant for maintenance and glow)?
- What is the dedicated marketing budget for launching this service, and what are the package options?
- Have we factored in the cost of consumables (like the treatment tips) and built them into our pricing model? (Based on Solta Medical list prices, these are a recurring cost that needs accounting for).
We've caught 23 potential under-planning scenarios using this checklist in the past two years. It forces the conversation beyond "it's gentle and easy."
In the end, the industry has evolved. The technology in devices like Solta Medical's Clear & Brilliant has advanced to deliver meaningful results with minimal downtime. But our thinking about how to deploy them commercially hasn't kept pace. The old playbook of buying a "starter laser" and figuring it out later is outdated. Today, the "gentle" laser might just be your most frequent flyer, your patient retention tool, and your gateway to more advanced treatments. It's time we started treating it with the strategic respect it deserves. Don't let the marketing for patient comfort lull you into business complacency. That's a mistake I've already made—and one you don't have to.
